Compare GFI & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GFI | ALC |
|---|---|---|
| Founded | 1887 | 1945 |
| Country | South Africa | Switzerland |
| Employees | N/A | N/A |
| Industry | Precious Metals | Ophthalmic Goods |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.5B | 39.0B |
| IPO Year | 2007 | N/A |
| Metric | GFI | ALC |
|---|---|---|
| Price | $49.99 | $81.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 12 |
| Target Price | $45.71 | ★ $88.29 |
| AVG Volume (30 Days) | ★ 3.5M | 1.3M |
| Earning Date | 02-19-2026 | 02-24-2026 |
| Dividend Yield | ★ 1.08% | 0.27% |
| EPS Growth | ★ 198.42 | N/A |
| EPS | 2.08 | ★ 2.10 |
| Revenue | $6,555,200,000.00 | ★ $10,185,000,000.00 |
| Revenue This Year | $65.51 | $5.76 |
| Revenue Next Year | $27.68 | $7.24 |
| P/E Ratio | ★ $28.12 | $37.80 |
| Revenue Growth | ★ 50.41 | 4.34 |
| 52 Week Low | $16.34 | $71.55 |
| 52 Week High | $61.64 | $99.20 |
| Indicator | GFI | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 49.54 | 54.96 |
| Support Level | $52.96 | $79.81 |
| Resistance Level | $61.52 | $81.42 |
| Average True Range (ATR) | 2.93 | 1.27 |
| MACD | 0.29 | 0.02 |
| Stochastic Oscillator | 17.71 | 74.38 |
Gold Fields Ltd is a producer of gold and is a holder of gold reserves and resources in South Africa, Ghana, Australia and Peru. In Peru, the company also produces copper. The company is involved in underground and surface gold and surface copper mining and silver and related activities, including exploration, extraction, processing and smelting. It conducts underground and surface mining operations at St. Ives, underground-only operations at Agnew, Granny Smith and South Deep and surface-only open pit mining at Damang, Tarkwa and Cerro Corona. The company's revenues are derived from the sale of gold that it produces.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.